Robb Wesselingh

6PUBLICATIONS
37CO-AUTHORS
Neurology and neuromuscular diseasesAutoimmunityMajor global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

|Feb 22, 2026
A qualitative exploration of patient experiences living with autoimmune encephalitis.

Robb Wesselingh, Nabil Seery, Katherine Ko

|Jun 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study.

Nabil Seery, Robb Wesselingh, Paul Beech

|May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study.

Nabil Seery, Robb Wesselingh, Paul Beech

|Mar 13, 2023
An eye to the future: Acute and long-term neuro-ophthalmological and neurological complications of COVID-19.

Robb Wesselingh, Steve L Wesselingh

Pageof 1